Cargando…
Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910800/ https://www.ncbi.nlm.nih.gov/pubmed/33638680 http://dx.doi.org/10.1007/s00415-021-10463-3 |
| _version_ | 1783656197013897216 |
|---|---|
| author | Khayat-Khoei, Mahsa Conway, Sarah Rubinson, Douglas A. Jarolim, Petr Houtchens, Maria K. |
| author_facet | Khayat-Khoei, Mahsa Conway, Sarah Rubinson, Douglas A. Jarolim, Petr Houtchens, Maria K. |
| author_sort | Khayat-Khoei, Mahsa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7910800 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79108002021-03-01 Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab Khayat-Khoei, Mahsa Conway, Sarah Rubinson, Douglas A. Jarolim, Petr Houtchens, Maria K. J Neurol Letter to the Editors Springer Berlin Heidelberg 2021-02-27 2021 /pmc/articles/PMC7910800/ /pubmed/33638680 http://dx.doi.org/10.1007/s00415-021-10463-3 Text en © Springer-Verlag GmbH, DE part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editors Khayat-Khoei, Mahsa Conway, Sarah Rubinson, Douglas A. Jarolim, Petr Houtchens, Maria K. Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab |
| title | Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab |
| title_full | Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab |
| title_fullStr | Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab |
| title_full_unstemmed | Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab |
| title_short | Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab |
| title_sort | negative anti-sars-cov-2 s antibody response following pfizer sars-cov-2 vaccination in a patient on ocrelizumab |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910800/ https://www.ncbi.nlm.nih.gov/pubmed/33638680 http://dx.doi.org/10.1007/s00415-021-10463-3 |
| work_keys_str_mv | AT khayatkhoeimahsa negativeantisarscov2santibodyresponsefollowingpfizersarscov2vaccinationinapatientonocrelizumab AT conwaysarah negativeantisarscov2santibodyresponsefollowingpfizersarscov2vaccinationinapatientonocrelizumab AT rubinsondouglasa negativeantisarscov2santibodyresponsefollowingpfizersarscov2vaccinationinapatientonocrelizumab AT jarolimpetr negativeantisarscov2santibodyresponsefollowingpfizersarscov2vaccinationinapatientonocrelizumab AT houtchensmariak negativeantisarscov2santibodyresponsefollowingpfizersarscov2vaccinationinapatientonocrelizumab |